A detailed history of Mediolanum International Funds LTD transactions in Amgen Inc stock. As of the latest transaction made, Mediolanum International Funds LTD holds 22,550 shares of AMGN stock, worth $6.32 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
22,550
Previous 23,035 2.11%
Holding current value
$6.32 Million
Previous $6.75 Billion 7.69%
% of portfolio
0.1%
Previous 0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$309.38 - $337.38 $150,049 - $163,629
-485 Reduced 2.11%
22,550 $7.26 Billion
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $55,703 - $67,693
212 Added 0.93%
23,035 $6.75 Billion
Q1 2024

May 03, 2024

BUY
$268.87 - $324.56 $6.14 Million - $7.41 Million
22,823 New
22,823 $6.53 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mediolanum International Funds LTD Portfolio

Follow Mediolanum International Funds LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mediolanum International Funds LTD, based on Form 13F filings with the SEC.

News

Stay updated on Mediolanum International Funds LTD with notifications on news.